siRNA targeting superoxide dismutase 1 (SOD1)

Details siRNA targeting superoxide dismutase 1 (SOD1) siRNA targeting superoxide dismutase 1 (SOD1)

2009-10-29

2011-10-18

McGarry, Sean (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C536S024100, C514S04400A

Reexamination Certificate

active

08039610

ABSTRACT:
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for SOD1.

REFERENCES:
patent: 5958773 (1999-09-01), Monia
patent: 6001992 (1999-12-01), Ackerman
patent: 6111086 (2000-08-01), Scaringe
patent: 6172216 (2001-01-01), Bennett et al.
patent: 6291642 (2001-09-01), Weinstein
patent: 6506559 (2003-01-01), Fire et al.
patent: 6566127 (2003-05-01), Pavco
patent: 6590093 (2003-07-01), Scaringe
patent: 6965025 (2005-11-01), Gaarde et al.
patent: 6994979 (2006-02-01), Reed
patent: 7022831 (2006-04-01), Reed
patent: 7022837 (2006-04-01), Harding
patent: 7033830 (2006-04-01), Karras
patent: 7157570 (2007-01-01), Yen
patent: 7176304 (2007-02-01), McSwiggen
patent: 7250496 (2007-07-01), Bentwich
patent: 7399853 (2008-07-01), Freier
patent: 7507811 (2009-03-01), Khvorova
patent: 7511132 (2009-03-01), Khvorova
patent: 7514550 (2009-04-01), Khvorova
patent: 7521191 (2009-04-01), Khvorova
patent: 7541453 (2009-06-01), Khvorova
patent: 7550572 (2009-06-01), Khvorova
patent: 7569684 (2009-08-01), Khvorova
patent: 7576196 (2009-08-01), Khvorova
patent: 7576197 (2009-08-01), Khvorova
patent: 7579457 (2009-08-01), Khvorova
patent: 7579458 (2009-08-01), Khvorova
patent: 7582746 (2009-09-01), Khvorova
patent: 7582747 (2009-09-01), Khvorova
patent: 7589191 (2009-09-01), Khvorova
patent: 7592442 (2009-09-01), Khvorova
patent: 7592443 (2009-09-01), Khvorova
patent: 7592444 (2009-09-01), Khvorova
patent: 7595387 (2009-09-01), Leake
patent: 7595388 (2009-09-01), Khvorova
patent: 7595389 (2009-09-01), Khvorova
patent: 7598369 (2009-10-01), Khvorova
patent: 7598370 (2009-10-01), Khvorova
patent: 7605250 (2009-10-01), Khvorova et al.
patent: 7605252 (2009-10-01), Khvorova et al.
patent: 2002/0081578 (2002-06-01), Plowman et al.
patent: 2002/0086321 (2002-07-01), Craig
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2002/0150945 (2002-10-01), Finney
patent: 2003/0087259 (2003-05-01), Clancy et al.
patent: 2003/0105051 (2003-06-01), McSwiggen
patent: 2003/0143732 (2003-07-01), Fosnaugh
patent: 2003/0157030 (2003-08-01), Davis et al.
patent: 2003/0224512 (2003-12-01), Dobie
patent: 2003/0228597 (2003-12-01), Cowsert
patent: 2004/0006365 (2004-01-01), Brady
patent: 2004/0029275 (2004-02-01), Brown et al.
patent: 2004/0054155 (2004-03-01), Woolf
patent: 2004/0063654 (2004-04-01), Davis et al.
patent: 2004/0077574 (2004-04-01), Klinghoffer
patent: 2004/0101857 (2004-05-01), Ward
patent: 2004/0101915 (2004-05-01), Deveraux
patent: 2004/0102391 (2004-05-01), Dean
patent: 2004/0180357 (2004-09-01), Reich
patent: 2004/0191818 (2004-09-01), O'Toole
patent: 2004/0192629 (2004-09-01), Xu et al.
patent: 2004/0204380 (2004-10-01), Ackerman
patent: 2004/0219671 (2004-11-01), McSwiggen
patent: 2004/0248296 (2004-12-01), Beresford
patent: 2004/0248299 (2004-12-01), Jayasena
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2005/0048529 (2005-03-01), McSwiggen
patent: 2005/0107328 (2005-05-01), Wyatt
patent: 2005/0130181 (2005-06-01), McSwiggen
patent: 2005/0176025 (2005-08-01), McSwiggen
patent: 2005/0181382 (2005-08-01), Zamore
patent: 2005/0186586 (2005-08-01), Zamore
patent: 2005/0227935 (2005-10-01), McSwiggen
patent: 2005/0239731 (2005-10-01), McSwiggen
patent: 2005/0245475 (2005-11-01), Khvorova
patent: 2005/0272680 (2005-12-01), Bhanot
patent: 2006/0025372 (2006-02-01), Bhanot
patent: 2006/0069056 (2006-03-01), Feinstein et al.
patent: 2006/0286575 (2006-12-01), Farrell
patent: 2007/0031844 (2007-02-01), Khvorova
patent: 2007/0254850 (2007-11-01), Lieberman
patent: 2007/0269395 (2007-11-01), Christiano
patent: 2007/0275465 (2007-11-01), Woppman
patent: 2007/0281901 (2007-12-01), Yanni
patent: 2008/0113351 (2008-05-01), Naito
patent: 2008/0124370 (2008-05-01), Marx
patent: WO9800532 (1998-01-01), None
patent: WO9938965 (1999-08-01), None
patent: WO9954459 (1999-10-01), None
patent: WO0032765 (1999-12-01), None
patent: WO0020645 (2000-04-01), None
patent: WO0021559 (2000-12-01), None
patent: WO0076497 (2000-12-01), None
patent: WO0244321 (2002-06-01), None
patent: WO03035869 (2003-05-01), None
patent: WO03035870 (2003-05-01), None
patent: WO03046176 (2003-06-01), None
patent: WO03070897 (2003-08-01), None
patent: WO03070910 (2003-08-01), None
patent: WO03070969 (2003-08-01), None
patent: WO03646625 (2003-08-01), None
patent: WO03072704 (2003-09-01), None
patent: WO2004031237 (2004-04-01), None
patent: WO2004046324 (2004-06-01), None
patent: WO2004048511 (2004-06-01), None
patent: WO2004090105 (2004-10-01), None
patent: WO2004094636 (2004-11-01), None
patent: WO2005001043 (2005-01-01), None
patent: WO2005078095 (2005-08-01), None
patent: WO2005089224 (2005-09-01), None
patent: WO2005117991 (2005-12-01), None
patent: WO2006015389 (2006-02-01), None
patent: WO2006110813 (2006-10-01), None
Abeliovich, et al. (2000) Mice Lacking Alph-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System. Neuron v.25:239-52.
Amarzguioui, Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes (2000) vol. 29, No. 21, 4113-4124.
Amarzguioui M et al, Tolerance for mutations and chemical modifications in a siRNA Nucleic Acids Research vol. 31, No. 2, Jan. 15, 2003 pp. 589-595 , XP002270887 ISSN: 0305-1048.
Bass, B.L., (2001) The Short Answer, Nature V.411:428-29.
Betrand (2002) Comparison of Antisense Oligonucleotides and siRNAs in cell culture and in vivo, Biotechnical and Biophysicial Research Communication 296:1000-1004.
Boutla, Shot 5′-phosphorylated double-stranded RNAs induce RNA interference inDrosophila, 1776-1780 (Brief Communication) (2001).
Brown et al. (1997) Identification and cDNA Cloning of a Novel Mammalian C2 Domain-Containing Phosphoinositide 3-kinase, HsC2-PI3K. Biochemical and Biophysical Research Communications. 233, 537-544.
Brummelkarna et al. A System for Stable Expression of Short Intereferring RNAs in Mammalian Cells, Science vol. 296 pp. 550-553 (2002).
Cahill et al. (1999) Characterization of MAD2B and Other Mitotic Spindle Checkpoint Genes. Genomics. 58:181-187.
Caplen et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate systems, Proc. Natl. Acad. Sci USA vol. 98, pp. 9742-9747 (2001).
Caplen, dsRNA-mediated gene silencing in culturedDrosophilacells: a tissue culture model for analysis of RNA interference, Jul. 11, 2000; Gene; 252(1-2):95-105.
Caplen, RNAi as a gene therapy approach. Expert Opin. Ther. 3(4):575-586. (2003).
Chalk, siRNA db: a database of siRNA sequences. Nucleic Acids Research. vol. 33 pp. D131-D134 (2004).
Chen et al. (2005) TSSK5, A Novel Member of the Testis-Specific Serine/Threonin Kinase Family, Phosphorylates CREB at Ser-122, and Stimulates the CRE-CREB Responsive Pathway. Biochemical and Biophysical Research Communications. 333: 742-749.
Cherry, Michael J. (1995) Computer Manipulation of DNA and Protein Sequences. Current Protocols in Molecular Biology. 7.7.1-7.7.23.
Chi, Genomewide view of gene silencing by small interfering RNAs. PNAS vol. 100, No. 11, pp. 6343-6346 (2003) (2003).
Chinault, Overlap Hybridization Screening: Isolation and Characterization of Overlapping DNA Framgments Surroungin the leu2 Gene on Yeast Chromosome III (1979), 5(2):111-26.
Daniel et al., Specific association of Type I with Ran GTPase in lipopolysacchardie-mediated differentiation, Oncogene 2001, vol. 20: 2618-2625.
Dodelet et al. (2000) Eph Receptors and Ephrin Ligands: embryogenesis to tumorigenesis. Oncogene 19:5614-5619.
Domin et al.(1997) Cloning of Human Phosphoinositide 3-Kinase with a C2 Domain that Displays Reduced Sensitivity to the Inhibitor Wortmannin. Biochem. J., v.325:139-47.
Dottori, et al. (1998) EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract, Proc. Natl. Acad. Sci. v

Affiliated with

Also associated with

Rating

siRNA targeting superoxide dismutase 1 (SOD1) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with siRNA targeting superoxide dismutase 1 (SOD1), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and siRNA targeting superoxide dismutase 1 (SOD1) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4297052